oncology

1,857 projects

H2020Individual fellowship2018–2019Italy

THAT IS HUNT · Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cell receptors

H2020Individual fellowship2018–2020Italy

IC_IL_EC_2017 · Investigating the effects of immunogenic chemoradiation in shaping the immune landscape of esophageal cancers

H2020Individual fellowship2018–2020France

RoNDBioCan · NLRP3 in cancer: Deciphering the role of NLRP3 in the DNA Damage response pathway

2 partners

H2020Individual fellowship2018–2020Spain

CINK · Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers

H2020Individual fellowship2018–2020Spain

DUALITY · An Integrated Computational and Experimental Approach to Rapid Synthesis of Highly Selective Dual-Targeted HDAC/CK2, MMP2/CK2 Inhibitors

H2020Individual fellowship2018–2020United Kingdom

JTIM · Biodegradable Water-Soluble Cylindrical Block Copolymer Micelles and their Applications in Nanomedicine

H2020Individual fellowship2018–2020Portugal

DevoSignGammaDelta · Tracking γδ T cell development and TCRγδ proximal signalling

H2020Individual fellowship2018–2019Denmark

DNAmethAML · Investigation of aberrant DNA methylation in malignant haematopoiesis

H2020Individual fellowship2018–2020Portugal

TRIBBLES · Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma

H2020Individual fellowship2018–2020Spain

PhoRAu · Photochemistry and radiolabelling of gold(III) anticancer prodrugs

H2020Individual fellowship2018–2019Switzerland

DREMATURE · DNA repair mechanisms and therapy resistance of BRCA2-deficient cancers

H2020Individual fellowship2018–2020Sweden

DrugSearchTool · Innovative FRET-based toolkit for screening of drugs to fight miRNA-related diseases and its use in the development of cancer treatment with miRNA-96 as a therapeutic target

H2020Individual fellowship2018–2020United Kingdom

MATESI · Multi-modal Approaches for Treatment and Evaluation of Swallowing Insufficiencies

H2020Individual fellowship2018–2020Ireland

TSPO METALLODRUGS · Novel, highly effective and selective anticancer metallodrugs

H2020Individual fellowship2018–2020United Kingdom

BRAINHIB · Integrated drug discovery approach to generate brain-penetrant inhibitors of glioblastoma cell proliferation

H2020Staff exchange2017–2022Italy

Nano-OligoMed · Hybrid Nanostructured Oligonucleotide Platforms for Biomedical Applications

8 partners · 6 countries

H2020Individual fellowship2017–2019Sweden

GOTBONE · Novel mechanisms of site-specific regulation of bone strength for the prevention of osteoporotic fractures: a translational project

H2020Individual fellowship2017–2019United Kingdom

ORI NUMBER · Unravelling the effect of origin number on the success of genome replication

H2020Doctoral network2017–2021Spain

VIRO-FLOW · Enabling Technologies and Drug Discovery: Continuous Flow Processes to Discover Novel Antiviral Inhibitors

2 partners · 2 countries

H2020Individual fellowship2017–2019France

ESEMT · DETERMINING THE FUNCTIONAL CONSEQUENCES OF TRANSCRIPTIONAL ENHANCER ACTIVATION ON ALTERNATIVE SPLICING DURING EMT

H2020Doctoral network2017–2022Netherlands

PREDICT · A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology

18 partners · 6 countries

H2020Doctoral network2017–2021Ireland

GLIOTRAIN · Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics

23 partners · 8 countries

H2020Doctoral network2017–2022Netherlands

DRIVE · Driving next generation autophagy researchers towards translation

35 partners · 11 countries

H2020Individual fellowship2017–2019Switzerland

ADVaNCE · ADVerse outcome Network for non-mutagenic CarcinogEns